Year: 2012
Type: dissertation
Abstract: Parkinson’s disease (PD) is the most common motor and age-related neurodegenerative disorder affecting more than 1% of the population above age 65. Neurologically, PD patients present symptoms of progressive deterioration of tremor, rigidity of movements, bradykinesia and postural instability. The major neuropathological features of the disease are characterized by a progressive degeneration of dopaminergic neurons in the substantia nigra pars compacta (SN) and the formation of intracytoplasmic inclusions, called Lewy bodies (LBs), which are mainly composed by alpha-synuclein (alpha-syn). Despite the efforts over the years, the etiopathogenesis of PD is still not fully understood. 95% of cases are sporadic and result from a combination of environmental factors and genetic susceptibilities. The remaining 5% are the result of genetic mutations, including in the alpha-syn gene, which is involved in autosomal dominant inherited forms of PD. Nevertheless, sporadic and genetic forms of PD share common processes, namely oxidative stress and mitochondrial dysfunction, which have been of great interest to understand the mechanisms involved in dopaminergic neurodegeneration in PD. In this study, we modelled mitochondrial dysfunction and oxidative stress in PD, respectively, by using rotenone, a complex I inhibitor of the mitochondrial respiratory chain and iron (FeSO4), a classical oxidative stress inducer, in the human neuroblastoma cell line SH-SY5Y, expressing wild-type (WT) or mutant A53T alpha-syn, using two different systems of protein overexpression. In the first part of the work, we focused on the effect of mutant A53T versus WT alpha-syn modifications in transiently transfected SH-SY5Y cells and analysed the susceptibility of these cells to prolonged exposure (4 days) to iron (FeSO4) and rotenone on the generation of reactive oxygen species (ROS) and its correlation with cell death, formation of alpha-syn inclusions and alpha-syn phosphorylation at serine (Ser) 129. Our data showed that mutant A53T alpha-syn increased ROS levels, ubiquitin (Ub)-labelled alpha-syn aggregates, Abstract 30 phosphorylation at Ser129 and a decrease in protein phosphatase 2A (PP2A) activity, when compared to WT alpha-syn. Furthermore, prolonged exposure to iron or rotenone, enhanced the production of ROS in cells expressing WT or mutant A53T alpha-syn, which correlated with alpha-syn inclusion formation, Ser129 phosphorylation and mitochondrial depolarization. Our data suggest that enhanced ROS formation is associated with alpha-syn aggregation and phosphorylation at Ser129, in particular mutant A53T alpha-syn, which may precede degeneration of PD affected cells. Next, we used the neuroblastoma cell line SH-SY5Y overexpressing WT alpha-syn in a doxycycline (Dox) regulated manner, in a Tet Off system. Here, we correlated the occurrence of oxidative stress in cells inducibly overexpressing WT alpha-syn (-Dox) before and after short exposure (2 h) to iron. We gave evidence for raised ROS generation under basal conditions in cells overexpressing WT alpha-syn, compared to cells expressing the endogenous protein (+Dox), without changes in cell reducing capacity or alterations in the levels of apoptotic proteins. Furthermore, increased ROS levels were closely related with a decrease in the activities and levels of proteins involved in the antioxidant defense pathways, namely superoxide dismutase 1 (SOD1), SOD2, reduced glutathione (GSH) and oxidized glutathione (GSSG), while enzymes of the glutathione redox cycle were unchanged. Accordingly, the levels of the catalytic subunit of glutamate-cysteine ligase (GCLc) were also diminished. Further analysis of nuclear fractions demonstrated that nuclear factor erythroid 2-related factor 2 (Nrf2), which activates the gene transcription of these antioxidant enzymes following mild intracellular ROS production, showed decreased levels in –Dox cells. Short treatment with iron, although largely augmenting ROS production in both +Dox and –Dox cells, triggered a significant increase in the levels and activities of these antioxidant proteins, apparently independently of alpha-syn overexpression, suggesting a compensatory intrinsic defense mechanism against short oxidizing stimulus. Finally, we investigated the role of WT alpha-syn expression in mitochondrial dysfunction, strongly associated with PD pathology. Using the same cellular model regulated by Dox, we showed that cells overexpressing alpha-syn and retaining high amount of alpha-syn in Abstract 31 mitochondria, displayed increased levels of mitochondrial superoxide anion, which were not triggered by treatment with iron. Accordingly, mitochondria from –Dox cells showed a significant decrease in the activity of complex I of the respiratory chain, with no changes in citrate synthase activity, corroborating previous studies concerning mitochondrial dysfunction and PD pathogenesis. Moreover, we did not find changes in mitochondrial transcription factor A (TFAM) or peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1alpha) between +Dox and –Dox cells. In addition, we observed a reduction in SOD1 activity in mitochondrial fractions of –Dox cells, which was exacerbated by iron. In contrast, mitochondrial SOD2 activity was not affected under basal conditions in –Dox cells, but was highly increased upon iron treatment. GSH and GSSG remained decreased in mitochondrial fractions from –Dox cells in untreated conditions, while iron did not affect the levels of this endogenous antioxidant. These data show that enhanced alphasyn in mitochondria may decrease the activity of mitochondrial complex I and promote mitochondrial ROS production, which may be boosted due to low antioxidant defenses in the organelle. Overall, these studies add relevant information on a close relationship between overexpression and post-translational modifications (e.g. phosphorylation) of WT and mutant alpha-syn and oxidative stress-related mechanisms, including cellular and mitochondrial antioxidant defense pathways. Thus, the data reveal the importance of developing neuroprotective strategies targeted at the transcription level, in order to prevent the imbalance in the redox homeostasis that trigger subsequent neurodegenerative events in PD.
Author: Rita Perfeito
Institution: University of Coimbra
Language: English
Subfield: Clinical Neurology
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W2561878015
